You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gestational trophoblastic neoplasia

Showing 1 - 25 of 2,399
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gestational Trophoblastic Neoplasia Trial in Miami (Dostarlimab)

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center
Nov 4, 2022

Gestational Trophoblastic Disease, Gestational Trophoblastic Neoplasia, GTD, Recurrent Trial (Pembrolizumab)

Not yet recruiting
  • Gestational Trophoblastic Disease
  • +2 more
  • (no location specified)
Nov 22, 2022

Gestational Trophoblastic Neoplasia Trial in Beijing (Toripalimab, Actinomycin-D)

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 1, 2023

Gestational Trophoblastic Neoplasia Trial in Beijing (Camrelizumab plus apatinib CohortA, Camrelizumab plus apatinib Cohort B)

Recruiting
  • Gestational Trophoblastic Neoplasia
  • Camrelizumab plus apatinib CohortA
  • Camrelizumab plus apatinib Cohort B
  • Beijing, China
    Peking Union Medical College Hospital
Jul 7, 2022

Gestational Trophoblastic Neoplasia Trial in Beijing (Toripalimab, Actinomycin-D)

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 7, 2023

Gestational Trophoblastic Neoplasia, Molar Pregnancy, GTD, Non-Metastatic Trial in Brazil (Uterine curettage, Chemotherapy)

Recruiting
  • Gestational Trophoblastic Neoplasia
  • +2 more
  • Botucatu, Brazil
  • +6 more
May 23, 2022

GTD, Gestational Trophoblastic Neoplasia, Stage I GTD Trial in Beijing (Methotrexate, Leucovorin, Dactinomycin)

Recruiting
  • Gestational Trophoblastic Tumor
  • +6 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 14, 2021

Gestational Trophoblastic Neoplasia Trial in Hangzhou (PD-1 inhibitor, bevacizumab)

Recruiting
  • Gestational Trophoblastic Neoplasia
  • PD-1 inhibitor， bevacizumab
  • Hangzhou, Zhejiang, China
    Women's Hospital School of Medicine Zhejiang University
Jun 2, 2022

Hydatidiform Mole, Gestational Trophoblastic Neoplasia Trial in Hangzhou (Follow up, chemo)

Recruiting
  • Hydatidiform Mole
  • Gestational Trophoblastic Neoplasia
  • Hangzhou, Zhejiang, China
    Weiguo Lv
Oct 21, 2021

Gestational Trophoblastic Disease Trial in Beijing (Apatinib, Camrelizumab)

Completed
  • Gestational Trophoblastic Disease
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jul 24, 2021

Gestational Trophoblastic Neoplasia Trial in Seongnam-si (Pembrolizumab Injection [Keytruda])

Not yet recruiting
  • Gestational Trophoblastic Neoplasia
  • Pembrolizumab Injection [Keytruda]
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    CHA Bundang Medical Center
Mar 10, 2020

Gestational Trophoblastic Disease, Gestational Trophoblastic Neoplasia, GTD Trial in Wuhan, Jinan, Hangzhou (MTX 1, MTX 2,

Unknown status
  • Gestational Trophoblastic Disease
  • +3 more
  • MTX 1
  • +2 more
  • Wuhan, Hubei, China
  • +2 more
Dec 23, 2019

Gestational Trophoblastic Tumors Trial in Hangzhou (Etoposide, actinomycin D, methotrexate)

Recruiting
  • Gestational Trophoblastic Neoplasms
  • Hangzhou, Zhejiang, China
    Weiguo Lv
Jun 2, 2022

Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

Recruiting
  • Adenocarcinoma
  • +75 more
  • Biomarker Testing (L)
  • +2 more
  • Idaho Falls, Idaho
  • +1 more
Oct 18, 2022

Choriocarcinoma, FIGO Stage I GTD, FIGO Stage II GTD Trial in Worldwide (biological, drug, other)

Completed
Has Results
  • Choriocarcinoma
  • +4 more
  • Dactinomycin
  • +3 more
  • Anchorage, Alaska
  • +288 more
Aug 10, 2022

Gestational Trophoblastic Neoplasia, Choriocarcinoma, Placental Site Trophoblastic Tumor Trial in Boston, Columbus, Dallas

Terminated
Has Results
  • Gestational Trophoblastic Neoplasia
  • +3 more
  • Boston, Massachusetts
  • +2 more
Jul 9, 2019

Gestational Trophoblastic Neoplasias (GTN) Trial in France (Avelumab administration at 10mg/kg)

Completed
  • Gestational Trophoblastic Neoplasias (GTN)
  • Avelumab administration at 10mg/kg
  • Bordeaux, France
  • +5 more
Sep 1, 2021

A Cohort Study of Hydatidiform Mole

Not yet recruiting
  • Hydatidiform Mole
  • No intervention
  • (no location specified)
Dec 5, 2022

Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles

Recruiting
  • Hydatidiform Moles
    • Houston, Texas
      Baylor College of Medicine
    Apr 19, 2022

    Gestational Trophoblastic Neoplasias (GTN) Trial in France (Avelumab Injection, Methotrexate 1 GM Injection)

    Recruiting
    • Gestational Trophoblastic Neoplasias (GTN)
    • Avelumab Injection
    • Methotrexate 1 GM Injection
    • Pierre-Bénite, Pierre Bénite, France
    • +7 more
    May 20, 2020

    Hydatidiform Mole Trial in Taft Avenue, Ermita, Manila (Methotrexate, Vitamin B Complex)

    Completed
    • Hydatidiform Mole
    • Taft Avenue, Ermita, Manila, Manila, Philippines
      Philippine General Hospital, University of the Philippines Manil
    Apr 16, 2020

    Good Prognosis Metastatic GTD, Hydatidiform Mole, Non-Metastatic GTD Trial in Philadelphia (Dactinomycin, Methotrexate)

    Completed
    Has Results
    • Good Prognosis Metastatic Gestational Trophoblastic Tumor
    • +3 more
    • Philadelphia, Pennsylvania
      Gynecologic Oncology Group
    Apr 12, 2018

    Viral Replication by Tonate Virus and Zika Virus, Withinex Vivo

    Not yet recruiting
    • Zika Virus Infection
    • Cell line and virus
    • +2 more
    • (no location specified)
    Oct 17, 2022

    Construction of Gynecological Tumor Organoids

    Not yet recruiting
    • Gynecologic Cancer
    • Organoid
    • construction of organoids from gynecological tumor
    • (no location specified)
    Nov 23, 2023

    Human Papillomavirus Infection Trial in Guangzhou, Nanjing, Taiyuan (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58)

    Active, not recruiting
    • Human Papillomavirus Infection
    • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
    • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)（GARDASIL®）
    • Guangzhou, Guangdong, China
    • +2 more
    Dec 30, 2022